Kintor Pharmaceutical Limited (KNTPF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 6.31% |
| 2022 | 968.86 Million CNY | 11.45% |
| 2021 | 869.34 Million CNY | 117.48% |
| 2020 | 399.73 Million CNY | 74.17% |
| 2019 | 229.5 Million CNY | 109.42% |
| 2018 | 109.59 Million CNY | 144.55% |
| 2017 | 44.81 Million CNY | -19.2% |
| 2016 | 55.46 Million CNY | 373.91% |
| 2015 | 11.7 Million CNY | 41.35% |
| 2014 | 8.27 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4510.21 USD | -100.0% |
| 2024 Q2 | 4481.11 USD | -0.65% |
| 2023 FY | 1.03 Billion CNY | 6.31% |
| 2023 Q3 | 55.5 Thousand USD | -99.82% |
| 2023 Q1 | 15.02 Thousand USD | -99.98% |
| 2023 Q2 | 30.99 Million USD | 206106.88% |
| 2023 Q4 | 110.81 Million USD | 199529.58% |
| 2022 Q4 | 62.27 Million USD | 0.0% |
| 2022 FY | 968.86 Million CNY | 11.45% |
| 2022 Q2 | 81.32 Million USD | 0.0% |
| 2021 Q4 | 84.08 Million USD | 0.0% |
| 2021 FY | 869.34 Million CNY | 117.48% |
| 2021 Q2 | 51.51 Million USD | 0.0% |
| 2020 Q4 | 31.52 Million USD | 0.0% |
| 2020 FY | 399.73 Million CNY | 74.17% |
| 2020 Q2 | 24.71 Million USD | 0.0% |
| 2019 Q2 | 14.62 Million USD | 0.0% |
| 2019 Q4 | 20.43 Million USD | 0.0% |
| 2019 FY | 229.5 Million CNY | 109.42% |
| 2018 FY | 109.59 Million CNY | 144.55% |
| 2017 FY | 44.81 Million CNY | -19.2% |
| 2016 FY | 55.46 Million CNY | 373.91% |
| 2015 FY | 11.7 Million CNY | 41.35% |
| 2014 FY | 8.27 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 3.65 Million USD | -28114.234% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -76678.565% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -39101.156% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -3385.328% |
| GB Sciences, Inc. | 1.42 Million USD | -72410.558% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -30150.377% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -467924.519% |
| Skye Bioscience, Inc. | 13.54 Million USD | -7502.991% |
| Zenith Capital Corp. | 8.94 Million USD | -11417.6% |
| Agentix Corp. | 1.37 Million USD | -74987.625% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -20328.6% |
| Biomind Labs Inc. | 994.18 Thousand USD | -103504.672% |
| ContraFect Corporation | 56.88 Million USD | -1710.577% |
| CSL Limited | 3.44 Billion USD | 70.136% |
| CytoDyn Inc. | 18.05 Million USD | -5603.948% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -55147.564% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -264301.667% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -1693.209% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -247811.206% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -68481.11% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -111433.064% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -2664.731% |
| SQZ Biotechnologies Company | 85.61 Million USD | -1103.026% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -50176.589% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -1086.863% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -35220.165% |
| Mesoblast Limited | 5.9 Million USD | -17352.033% |
| Marizyme, Inc. | 19.23 Million USD | -5253.576% |
| Genus plc | 147.7 Million USD | -597.372% |
| Pharming Group N.V. | 225.49 Million USD | -356.789% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -12251.829% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -69554.614% |
| IMV Inc. | 37.7 Million USD | -2631.478% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -36813.52% |
| MultiCell Technologies, Inc. | 567.42 USD | -181526635.046% |
| ONE Bio Corp. | 6.44 Million USD | -15884.424% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -1098.463% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -4067.586% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -58434.516% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -15232.193% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 4120176.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -6333.503% |
| Alpha Cognition Inc. | 9.7 Million USD | -10512.625% |
| Enzolytics Inc. | 2.17 Million USD | -47159.266% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 32.833% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -98560.824% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -42729.408% |
| Genscript Biotech Corporation | 825.34 Million USD | -24.799% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -20844.23% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -393448.597% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -41850.551% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -600462.653% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -53521.52% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -11632.447% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -23263.475% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 3.74 Million USD | -27393.428% |
| Helix BioMedix, Inc. | 1.97 Million USD | -52131.3% |
| EV Biologics, Inc. | 531.96 Thousand USD | -193526.424% |
| Q BioMed Inc. | 3.43 Million USD | -29871.792% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -9378.412% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -936.965% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 22.97 Million USD | -4383.255% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -56028.92% |
| HST Global, Inc. | 140.9 Thousand USD | -730892.073% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | -77030.08% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -91464.57% |
| Halberd Corporation | 74.84 Thousand USD | -1376157.983% |
| Resverlogix Corp. | 12.71 Million USD | -8002.73% |
| Cell Source, Inc. | 4.32 Million USD | -23713.563% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -65117.7% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.31 Million USD | -13990.038% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -5912413.633% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.46 Million USD | -41655.93% |
| Kadimastem Ltd | 2.41 Million USD | -42637.391% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -24201.991% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -567450.486% |
| LadRx Corporation | 3.81 Million USD | -26921.917% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -111433.064% |
| Affymax, Inc. | 39.38 Million USD | -2515.191% |
| Itoco Inc. | 919.14 Thousand USD | -111962.976% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -91948.168% |
| Mobile Lads Corp. | 554.54 Thousand USD | -185640.948% |
| International Stem Cell Corporation | 5.27 Million USD | -19441.245% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 3.82 Million USD | -26862.811% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -4092311.3% |
| Qrons Inc. | 643.67 Thousand USD | -159921.098% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -72447.176% |
| SYBLEU INC | 160.87 Thousand USD | -640156.471% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | -46091.699% |
| Rebus Holdings, Inc. | 664 Thousand USD | -155023.343% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -56609.115% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -1956548.684% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -5063160.089% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -2740.178% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -63560.012% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -139879.615% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -33008.936% |
| Neutra Corp. | 243.82 Thousand USD | -422348.846% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -5800.321% |
| PureTech Health plc | 144.59 Million USD | -612.338% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -4926.963% |
| IXICO plc | 4.7 Million USD | -21782.707% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -11608.753% |
| Gelesis Holdings, Inc. | 117.74 Million USD | -774.766% |
| CSL Limited | 3.89 Billion USD | 73.542% |
| Cellectis S.A. | 97.32 Million USD | -958.384% |